HRP20251599T1 - Postupak za dijagnosticiranje i liječenje parcijalne lipodistrofije - Google Patents
Postupak za dijagnosticiranje i liječenje parcijalne lipodistrofijeInfo
- Publication number
- HRP20251599T1 HRP20251599T1 HRP20251599TT HRP20251599T HRP20251599T1 HR P20251599 T1 HRP20251599 T1 HR P20251599T1 HR P20251599T T HRP20251599T T HR P20251599TT HR P20251599 T HRP20251599 T HR P20251599T HR P20251599 T1 HRP20251599 T1 HR P20251599T1
- Authority
- HR
- Croatia
- Prior art keywords
- diagnosing
- procedure
- partial lipodystrophy
- treating partial
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4872—Body fat
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/482—Diagnostic techniques involving multiple energy imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Data Mining & Analysis (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Artificial Intelligence (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dentistry (AREA)
- Software Systems (AREA)
- Bioethics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Evolutionary Computation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163152100P | 2021-02-22 | 2021-02-22 | |
| EP22708698.0A EP4294257B1 (en) | 2021-02-22 | 2022-02-22 | Method for diagnosing and treating partial lipodystrophy |
| PCT/US2022/017222 WO2022178382A1 (en) | 2021-02-22 | 2022-02-22 | Method for diagnosing and treating partial lipodystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20251599T1 true HRP20251599T1 (hr) | 2026-01-30 |
Family
ID=80683255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20251599TT HRP20251599T1 (hr) | 2021-02-22 | 2022-02-22 | Postupak za dijagnosticiranje i liječenje parcijalne lipodistrofije |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240153638A1 (https=) |
| EP (1) | EP4294257B1 (https=) |
| JP (1) | JP2024512255A (https=) |
| DK (1) | DK4294257T3 (https=) |
| ES (1) | ES3055018T3 (https=) |
| FI (1) | FI4294257T3 (https=) |
| HR (1) | HRP20251599T1 (https=) |
| LT (1) | LT4294257T (https=) |
| PL (1) | PL4294257T3 (https=) |
| PT (1) | PT4294257T (https=) |
| RS (1) | RS67523B1 (https=) |
| SI (1) | SI4294257T1 (https=) |
| SM (1) | SMT202500444T1 (https=) |
| WO (1) | WO2022178382A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021013807A2 (pt) | 2019-01-18 | 2021-11-30 | Astrazeneca Ab | Inibidores de pcsk9 e seus métodos de uso |
| MX2021008661A (es) | 2019-01-18 | 2021-08-19 | Astrazeneca Ab | Inhibidores de la pcsk9 y metodos de uso de los mismos. |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202417497A (zh) | 2015-10-12 | 2024-05-01 | 美商再生元醫藥公司 | 活化瘦素受體的抗原結合蛋白 |
| PT3773713T (pt) * | 2018-04-06 | 2025-07-29 | Regeneron Pharma | Anticorpo agonista do recetor de leptina para usar no aumento da massa óssea num sujeito que sofre de disfunção metabólica ou de hipoleptinemia |
-
2022
- 2022-02-22 EP EP22708698.0A patent/EP4294257B1/en active Active
- 2022-02-22 JP JP2023550240A patent/JP2024512255A/ja active Pending
- 2022-02-22 LT LTEPPCT/US2022/017222T patent/LT4294257T/lt unknown
- 2022-02-22 HR HRP20251599TT patent/HRP20251599T1/hr unknown
- 2022-02-22 PT PT227086980T patent/PT4294257T/pt unknown
- 2022-02-22 SI SI202230205T patent/SI4294257T1/sl unknown
- 2022-02-22 US US18/547,150 patent/US20240153638A1/en active Pending
- 2022-02-22 DK DK22708698.0T patent/DK4294257T3/da active
- 2022-02-22 SM SM20250444T patent/SMT202500444T1/it unknown
- 2022-02-22 WO PCT/US2022/017222 patent/WO2022178382A1/en not_active Ceased
- 2022-02-22 FI FIEP22708698.0T patent/FI4294257T3/fi active
- 2022-02-22 RS RS20251266A patent/RS67523B1/sr unknown
- 2022-02-22 ES ES22708698T patent/ES3055018T3/es active Active
- 2022-02-22 PL PL22708698.0T patent/PL4294257T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022178382A1 (en) | 2022-08-25 |
| SI4294257T1 (sl) | 2026-01-30 |
| JP2024512255A (ja) | 2024-03-19 |
| US20240153638A1 (en) | 2024-05-09 |
| DK4294257T3 (da) | 2025-12-08 |
| SMT202500444T1 (it) | 2026-01-12 |
| RS67523B1 (sr) | 2026-01-30 |
| PL4294257T3 (pl) | 2026-02-09 |
| EP4294257A1 (en) | 2023-12-27 |
| FI4294257T3 (fi) | 2025-12-19 |
| LT4294257T (lt) | 2025-12-29 |
| PT4294257T (pt) | 2025-11-28 |
| EP4294257B1 (en) | 2025-11-05 |
| ES3055018T3 (en) | 2026-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20251599T1 (hr) | Postupak za dijagnosticiranje i liječenje parcijalne lipodistrofije | |
| IL288061A (en) | Compounds and methods for the treatment of covid-19 | |
| EP3975717C0 (en) | WATER TREATMENT PROCESS AND COMPOSITION | |
| EP3541408C0 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ABERRANT ANGIOGENESIS | |
| EP4047509A4 (en) | Facial parsing method and related devices | |
| EP3644789C0 (en) | COSMETIC TREATMENT PROCESS AND SET | |
| IL281044B (en) | Method and kit for treating damaged nerves | |
| EP4074183A4 (en) | CONCENTRATION PROCESS AND EQUIPMENT | |
| EP3900728A4 (en) | Ursodeoxycholic acid-containing agent for treating or preventing presbyopia | |
| EP4178604A4 (en) | COMPOSITIONS AND METHODS USEFUL FOR THE PREVENTION AND/OR TREATMENT OF DISEASE IN MAMMALS | |
| EP4199864A4 (en) | TOTAL ASTRAGALAR IMPLANT AND METHOD | |
| EP4014649C0 (en) | METHODS AND APPARATUS FOR RANDOM ACCESS | |
| IL309662A (en) | Compositions and methods for treating cancers | |
| EP3914337C0 (en) | ELECTRODE ASSEMBLY AND METHODS | |
| EP4355331A4 (en) | Methods and compositions for treating melanoma | |
| EP3824090A4 (en) | METHODS OF TREATING HEARING LOSS AND/OR LOSS OF VISION ASSOCIATED WITH CLRN1 | |
| IL287037A (en) | Method and apparatus for reconditioning organs | |
| EP4125835A4 (en) | Methods and compositions for treating or preventing an inflammatory condition | |
| EP4110932A4 (en) | TREATMENT OF AUTOSOMAL RECESSIVE BESTROPHINOPATHIES AND METHODS OF EVALUATION THEREOF | |
| EP4003282C0 (en) | TREATMENT OF AGING OR UV DAMAGED SKIN | |
| EP4623299A4 (en) | METHOD AND TREATMENT | |
| IL311572A (en) | Compositions and methods for treating kcnq4-associated hearing loss | |
| EP4440531C0 (en) | SKIN TREATMENT KIT AND PROCESS | |
| EP4479129A4 (en) | SKIN TREATMENT AND PRE-TREATMENT TECHNIQUES BASED ON MICROCURRENT | |
| EP4440411A4 (en) | Feature localization techniques for images and/or fundus measurements |